Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effects and Safety of Green Tea Extract(GTE) Consumption on Blood Glucose Regulation

NCT06592365 is registered in ClinicalTrials.gov with Amorepacific Corporation as lead sponsor.

NCT NCT06592365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06592365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effects and Safety of Green Tea Extract(GTE) Consumption on Blood Glucose Regulation
Lead sponsor
Amorepacific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
August 8, 2022
Completion date
December 31, 2024
Enrollment
84 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

blood sugar